C116H140N18O17 — CID 159123300
6-[2-[[(2S,6R)-2,6-dimethylmorpholin-4-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-[(4-methylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-(piperazin-1-ylmethyl)indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-[(4-propan-2-ylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid (PubChem CID 159123300) has the molecular formula C116H140N18O17 and a molecular weight of 2058.50 g/mol. Its IUPAC name is 6-[2-[[(2S,6R)-2,6-dimethylmorpholin-4-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-[(4-methylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-(piperazin-1-ylmethyl)indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-[(4-propan-2-ylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid.
| Compound Name | 6-[2-[[(2S,6R)-2,6-dimethylmorpholin-4-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-[(4-methylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-(piperazin-1-ylmethyl)indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-[(4-propan-2-ylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid |
|---|---|
| PubChem CID | 159123300 |
| Molecular Formula | C116H140N18O17 |
| Molecular Weight | 2058.50 g/mol |
| Exact Mass | 2057.06 |
| IUPAC Name | 6-[2-[[(2S,6R)-2,6-dimethylmorpholin-4-yl]methyl]-1-methylindol-5-yl]-5-ethyl-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-[(4-methylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-(morpholin-4-ylmethyl)indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-(piperazin-1-ylmethyl)indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-6-[1-methyl-2-[(4-propan-2-ylpiperazin-1-yl)methyl]indol-5-yl]-2-oxo-1H-pyridine-3-carboxylic acid |
| SMILES | CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)cc(CN1CCN(C(C)C)CC1)n2C.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)cc(CN1CCN(C)CC1)n2C.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)cc(CN1CCNCC1)n2C.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)cc(CN1CCOCC1)n2C.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)cc(CN1C[C@@H](C)O[C@@H](C)C1)n2C |
| InChI | InChI=1S/C25H32N4O3.C24H29N3O4.C23H28N4O3.C22H26N4O3.C22H25N3O4/c1-5-17-14-21(25(31)32)24(30)26-23(17)18-6-7-22-19(12-18)13-20(27(22)4)15-28-8-10-29(11-9-28)16(2)3;1-5-16-10-20(24(29)30)23(28)25-22(16)17-6-7-21-18(8-17)9-19(26(21)4)13-27-11-14(2)31-15(3)12-27;1-4-15-13-19(23(29)30)22(28)24-21(15)16-5-6-20-17(11-16)12-18(26(20)3)14-27-9-7-25(2)8-10-27;1-3-14-12-18(22(28)29)21(27)24-20(14)15-4-5-19-16(10-15)11-17(25(19)2)13-26-8-6-23-7-9-26;1-3-14-12-18(22(27)28)21(26)23-20(14)15-4-5-19-16(10-15)11-17(24(19)2)13-25-6-8-29-9-7-25/h6-7,12-14,16H,5,8-11,15H2,1-4H3,(H,26,30)(H,31,32);6-10,14-15H,5,11-13H2,1-4H3,(H,25,28)(H,29,30);5-6,11-13H,4,7-10,14H2,1-3H3,(H,24,28)(H,29,30);4-5,10-12,23H,3,6-9,13H2,1-2H3,(H,24,27)(H,28,29);4-5,10-12H,3,6-9,13H2,1-2H3,(H,23,26)(H,27,28)/t;14-,15+;;; |
| InChIKey | KFYUNGRHEKVSST-TYZKWYMUSA-N |
| XLogP | 14.09 |
| TPSA | 428.62 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 151 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2058.50 |
| LogP ≤ 5 | 14.09 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 25 |